One hundred years of forensic sciences in Quebec: the evolution of scientific techniques since 1914

In 2014, Quebec's forensic science laboratory (Laboratoire de sciences judiciaires et de medicine légale) is celebrating its 100th anniversary. Since its foundation by Dr. Derome in 1914, scientific techniques in the various areas of forensic science have greatly evolved. Not only was the Laboratory the first forensic science institution in North America, it has been a pioneer for several analytical methods. The early days of the Laboratory as well as the specific evolution of the departments and divisions of biology, chemistry, arson and explosion, questioned documents, forensic pathology, odontology and anthropology, toxicology and administration will be reviewed here

Cent ans de sciences judiciaires au Québec : l'évolution des techniques scientifiques depuis 1914

En 2014, le Laboratoire de sciences judiciaires et de médicine légale du Québec célèbre son 100ième anniversaire. Depuis sa fondation par Dr Wilfrid Derome en 1914, les techniques scientifiques ont grandement évolué dans les différents domaines des sciences judiciaires. Non seulement le laboratoire fut la première institution de sciences judiciaires en Amérique du Nord, mais plusieurs méthodes analytiques y furent aussi développées. Les débuts du Laboratoire ainsi que l'évolution spécifique des différentes directions et divisions de la biologie, chimie, incendies et explosions, documents, pathologie judiciaire, odontologie et anthropologie, toxicologie et administration seront relatés ici

Contribution of serology in congenital toxoplasmosis diagnosis: results from a 10-year French retrospective study

International audienceABSTRACT This study aimed to evaluate different serological strategies for the postnatal diagnosis of congenital toxoplasmosis (CT) and establish a biological algorithm for CT diagnosis. The study analyzed serological data of immunoglobulins M, A, and G (IgM, IgA, IgG) performed by immunoenzymatic and compared immunological profile (CIP) assays in 668 newborns with CT diagnosis across four testing periods: P1 (D0– D10), P2 (D11–D35), P3 (D36–D45), and P4 (>D45). Forty-nine percent of the 668 CT cases were diagnosed during P1 and 34%, 4%, and 12% during P2, P3, and P4, respectively. CIP assays detected neosynthetized IgMs/IgGs in 98% of CT cases diagnosed during P1, while IgMs and IgAs were detected in 90% and 57% of CT cases diagnosed during P2 and in 88% and 67% of diagnoses made during P3, respectively. Detection of neosynthesized IgMs/IgGs, IgMs, and IgAs by immunoassay contributed to CT diagnosis in 81%, 77%, and 60% of cases, respectively. In total, 46% of serum samples were positive for all three parameters, 27% for two, and 27% for one of the three. The study recommends using the CIP assay as standard during P1 for CT diagnosis and IgM and IgA immunoassays after P1. A clinical and biological follow-up in a specialized center with a close collaboration between biologists and clinicians is highly recommended to increase the chances of early diagnosis. Overall, this study provides useful information for the development of a biological algorithm for CT diagnosis, which can aid in early detection and appropriate treatment of this disease

Predictive neural biomarkers of clinical response in depression:a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies

We performed a systematic review and meta-analysis of neural predictors of response to the most commonly used, evidence based treatments in clinical practice, namely pharmacological and psychological therapies. Investigations of medication-free subjects suffering from a current major depressive episode who underwent positron emission tomography (PET) or functional or structural magnetic resonance imaging (MRI) scans prior to the initiation of treatment were reviewed. Results of 20 studies from 15 independent samples were included in the functional imaging meta-analysis and 9 studies from 6 independent samples in the structural neuroimaging meta-analysis. Regional activations with prognostic value include the well replicated finding that increased baseline activity in the anterior cingulate is predictive of a higher likelihood of improvement. As well, increased baseline activation in the insula and striatum is associated with higher likelihood of a poorer clinical response. Structural neuroimaging studies indicated that a decrease in right hippocampal volume is a statistically significant predictor of poorer treatment response. Overall, the predictive information that is measurable with brain imaging techniques is both multimodal and regionally distributed as it contains functional as well as structural correlates which encompass several brain regions within a frontostriatal–limbic network. To develop clinically relevant, prognostic markers will require high predictive accuracy at the level of the individual. Predicting clinical response will help to stratify patients and to identify at an early stage those patients who may require more intensive or combined therapies. We propose that structural and functional neuroimaging show significant potential for the development of prognostic markers of clinical response in the treatment of depression